*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ponatinib is a third-generation <strong>tyrosine kinase inhibitor</strong> synthesized via advanced organic coupling. Its chemical structure is defined by the molecular formula <strong>C24H20ClN5O</strong> and CAS number <strong>956817-05-7</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Production of pharmaceutical grade API for treating chronic myeloid leukemia (CML).</li>
<li><strong>Research & Development:</strong> Supply to laboratories studying T315I mutation resistance mechanisms.</li>
<li><strong>Contract Manufacturing:</strong> Custom synthesis services for global biotech firms requiring high-purity intermediates.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store below 25°C in a dry, inert atmosphere. Handle with appropriate PPE due to potential cytotoxicity. Clinical use requires rigorous monitoring for vascular occlusive events and hepatotoxicity.</p>